Keyword: Crescendo Bioscience
Ex-Gilead CMO Andrew Cheng to lead Akero; Sanofi trades executives with Bayer in restructuring; and Crescendo names ex-Roche leader as CMO.
Pisa is the former group head of translational medicine at Roche, where he worked on the development of oncology drugs including Avastin and Gazyva.
The financing equips Crescendo to show whether its vision for dialing up T-cell activity in the tumor microenvironment translates into humans.
Two years out from the U.K.'s scheduled EU exit date, the life science sector is increasingly confident about its post-Brexit prospects.
Takeda has been making some serious moves in R&D this year: signing deals here, cutting back there, and also handing over much of its R&D work to CRO PRA health--in October, it’s showing no signs of slowing down after penning a major oncology pact with early-stage UK biotech Crescendo Biologics.